ABSTRACT Men exposed to high concentrations of bacterial single-cell protein (Pruteen) dust have complained of "sticky eyes" and influenza-like symptoms. Over four years, surveillance of a work force of 70 men with a programme that included a respiratory health questionnaire, skin prick testing, serum testing for precipitating antibodies, lung function measurements, and chest radiography has shown no evidence of allergic reaction or of exposure-related deterioration in lung function. The symptoms experienced may be attributable to exposure to lipopolysaccharide. The results show that Pruteen can be produced and handled without adverse effects on health, provided that adequate measures are taken to prevent exposure to high concentrations of dust.
Research and development on the production of single cell protein (Pruteen) has been carried out at Billingham during the past 12 years. In 1971 a pilot plant capable of producing 1000 tonnes a year was commissioned, and more than 100 employees have been concerned to some degree in producing and handling the product.
Pruteen is produced by the fermentation of methanol by Methylophilus methylotrophus, a Gram-negative aerobic organism that is dependent on methanol as its source of carbon. Extensive toxicological tests and animal feeding trials have shown it to be non-toxic and non-pathogenic. The fermentation is carried out in a pressure cycle fermenter as a monoculture in a substrate containing methanol, ammonia, and several trace elements. The process is continuous, the culture being drawn from the fermenter and the organism killed by acid and heat shock before being flocculated, dried, and oiled for dust suppression. The final product is in the form of granules for inclusion in the diet of pigs, poultry, and fish, or is ground to a fine powder for use as a milk substitute in the production of veal. 
Materials and methods
In 1975 a medical surveillance programme was set up to monitor the health of the work force of 106 men with particular reference to allergic response and respiratory effects.
The programme was applied to the work force already working with Pruteen and included some men who had already been working on the pilot plant for up to four years. No selection was made on medical grounds, and the population contained atopics, including those with asthma, as well as men suffering from chronic bronchitis. Attendance was voluntary but only two men refused to take part. It was not possible to include a control group, but the population was divided into three categories based on a rough estimate of their degree of exposure:
Continuous exposure-Plant operators who spent all their working time on the plant and who were likely to receive the highest exposures. To detect sensitisation to Pruteen, an antigen extract was used which was prepared from sonicated 12 5% suspensions of Pruteen in buffer pH 9 6 (0 15 M) and pH 5 (0 05 M), both being centrifuged and mixed in equal quantities.
The presence of precipitating antibodies to Pruteen was detected in the serum from venous blood samples by simple Agar diffusion methods, using extracts of the organism and the final product.
Lung function was assessed by measuring FEV1 and FVC with a Vitalograph spirometer, and the gas transfer factor was measured with a Morgan respirometer. The measurements were all carried out by one trained technician, and the equipment was calibrated annually. Because of shift working and the demands of work on the plant it was possible to examine the men in groups of only 10 to 12 at a time. Sessions were held between 0900 and 1100 on Friday each week, and the initial programme extended over several months. The men were asked not to smoke for one hour before their examination.
Finally, everyone included in the programme participated in the annual mass miniature x-ray screening programme on the site. At these examinations the author interviewed the men and recorded any symptoms experienced since their last interview with particular reference to eye and respiratory symptoms. They were tested for sensitisation by skin prick test, and for the presence of precipitating antibodies, and lung function tests were repeated. New employees on the plant were seen and included in the surveillance programme on starting employment.
Atmospheric dust measurements taken on the plant were recorded, and all incidents involving exposure to high dust concentrations were recorded and investigated.
Results

POPULATION
Of the 104 men initially concerned in the programme, 26 left the project in the first four years. One man died (of a myocardial infarction) while seven retired on reaching retirement age, 11 were transferred to other works on the site, and seven left the company. There is no evidence that anyone left the project for medical reasons related to exposure to Pruteen. Of Lack of allergic reactions in workers exposed to Pruteen (bacterial single-cell protein) the 78 remaining subjects, eight had incomplete data recorded; the residual population of 70 was therefore used for analysis of the results.
Over the four years, a further 81 men have worked on the project and have been added to the survey but have not been included in these results. Of the residual population of 70, 20 were identified as atopics, 18 were heavy smokers and 15 light smokers, and with regard to exposure, 26 were assigned to category 1, 28 to category 2, and 16 to category 3.
SYMPTOMS
Eleven men complained that at some time they had experienced eye symptoms after exposure. Of these, four said that they had had more than one attack and thought that they had reacted more readily than their work mates. It was noticed that when several men were exposed to high concentrations of dust on the same occasion, some did not experience symptoms.
Four men complained of having experienced influenza-like symptoms with some tightness of the chest; in three cases they also had "sticky eyes." Only one of these men was identified as an atopic, and none showed any evidence of sensitisation by skin prick test. Similarly, no one developed precipitating antibodies in association with his symptoms, either at the time of exposure or subsequently.
SKIN PRICK TEST
No one in the survey has shown a positive reaction to the skin prick test for Pruteen.
PRECIPITIN TEST
Only one man has produced a positive reaction. This man was affected in the incident in 1971 and developed antibodies at that time, which have been detectable throughout the four years of the survey. No one has developed antibodies during the survey period.
RADIOGRAPHY
The films were all examined by a consultant radiologist, and no serious abnormalities were detected.
LUNG FUNCTION
The lung function data were analysed in an attempt to detect group exposure effects that were not apparent from the individual clinical records. For the 70 men in the study, the differences between the most recent and the initial lung function readings were used to calculate annual loss rates for FEV1 and FVC in ml/year and gas transfer factor (TL) in ml/min per mm Hg a year. Mean values for these loss rates were then evaluated for the three categories of exposure, the three categories of smoking and the two categories of atopy after ascertaining that there were no misleading interactions among these groups. The mean annual loss rates for the 26 continuously exposed men were 47 for FEV1, 90 for FVC, and 0-25 for TL. Taking into account the small numbers of men concerned, and the large standard errors of these mean values, they are not dissimilar from those for the 28 recurrently exposed men (54, 64, and 0 respectively) or the 16 occasionally exposed men (33, 75, and 0-24 respectively). By the same criteria, the differences between the mean values for the 20 atopics (52, 82, and 0-14 respectively) are barely distinguishable from those for the other 50 men (44, 74, and 0-14 respectively). Analysis for the three smoking groups also yielded similar figures. The means for the 18 heavy smokers were 51, 102, and 0-06; for the 15 light smokers 55, 81, and 0-17; and for the 37 non-smokers 42, 62, and 019.
Discussion
As a result of the medical surveillance programme, it has been possible to identify and evaluate the effects of exposure to high concentrations of Pruteen dust. The symptoms experienced fall into two distinct types: a conjunctivitis with profuse sterile purulent discharge, and general febrile symptoms resembling a mild attack of influenza. fnvariably they occur several hours after exposure, and complete recovery takes place within 24 to 48 hours. Some men appear to experience these symptoms more readily than others.
Symptoms occur only after exposure to high concentrations of dust and have not been reported during normal working conditions. When atmospheric dust has been measured the lowest recorded concentration at which symptoms have been produced has been 10 mg/m3. In the incident in 1971 men were exposed to an aerosol of whole organisms, and antibodies were present in most of the men. Immunisation studies in animals have shown that Pruteen contains far fewer antigens than does the parent organism; it seems that the immunogenicity of the organism is considerably reduced in the subsequent processing of the culture.
The lung function measurements are of value for assessing subclinical effects. Berry3 has shown that large numbers of men must be monitored over long periods if anything but gross effects are to be shown to be statistically significant, while Fletcher et a14 have discussed a wide range of factors that can cause such analyses to be misleading. Nevertheless, had a pronounced dose-effect relationship been observed for these 70 men over the period of four years it could have been regarded as the first indication of a chronic pulmonary problem.
In practice, the differences observed among the various exposure, smoking, and atopic categories are so small, by comparison with the variability in the data, as to make any interpretation extremely premature.
The overall mean rate of loss of FEV1 for the 70 men, 46 ml/year, is in line with published figures for studies inclusive of smokers, and the mean loss rate for gas transfer factor is close to its predicted value. The mean rate of loss of FVC, 76 ml/year, is high but, if it is correlated with anything, it is with smoking habits rather than with exposure category or atopic status.
Probably symptoms are produced as a reaction to exposure to the lipopolysaccharide (endotoxin). It has been shown experimentally in animals that Pruteen is capable of activating complement by the alternative pathway, but attempts to show C3 conversion in exposed men have so far been unsuccessful. Attempts to reproduce the eye symptoms in rabbits or guinea-pigs by exposure to direct contact with the dust have also been unsuccessful (G E Davies, personal communication).
Mayes
The results have shown that Pruteen can be produced and handled without adverse effects on health, provided that adequate measures are taken to prevent exposure to high concentrations of dust. 
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